Dan Dan Li
Impact in
- Pharmacology top 10%
- Berberine and alkaloids research
- Alkaloids: synthesis and pharmacology
-
- Natural Antidiabetic Agents Studies
Papers in
-
- RNA modifications and cancer 3
- Photosynthetic Processes and Mechanisms 2
- Oncology 4
- Cutaneous Melanoma Detection and Management 1
- Co-authors
- Ying Xu (1 shared paper)Le Zhang (1 shared paper)Xin‐Qi Gao (1 shared paper)Changzhen Liu (1 shared paper)Xian Sheng Zhang (1 shared paper)Xin‐Ying Zhao (1 shared paper)Ting Zhao (1 shared paper)Shi H (1 shared paper)
- Journals
- IEEE Transactions on Components Packaging and Manufacturing Technology (1 paper)International Journal of Medical Sciences (1 paper)Frontiers in Immunology (1 paper)Journal of Equine Veterinary Science (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Dan Dan Li
26 papers receiving 306 citations
Peers
Comparison fields: 5 of 98
- Pharmacology 53
- Pharmacology 87
- Endocrinology, Diabetes and Metabolism 39
- Plant Science 83
- Molecular Biology 144
Countries citing papers authored by Dan Dan Li
This map shows the geographic impact of Dan Dan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Dan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Dan Li more than expected).
Fields of papers citing papers by Dan Dan Li
This network shows the impact of papers produced by Dan Dan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Dan Li. The network helps show where Dan Dan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Dan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 130 | |
| 2 | 2016 | 69 | |
| 3 | 2012 | 35 | |
| 4 | 2014 | 14 | |
| 5 | 2015 | 11 | |
| 6 | 2023 | 7 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 5 | |
| 9 | 2010 | 4 | |
| 10 | 2024 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 2025 | 3 | |
| 13 | 2012 | 3 | |
| 14 | 2020 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2013 | 2 | |
| 17 | 2011 | 2 | |
| 18 | 2020 | 2 | |
| 19 | The prognostic value of preoperative serum HDL cholesterol in patients with resectable acral melanoma | 2017 | 1 |
| 20 | 2011 | 1 |
About Dan Dan Li
Dan Dan Li is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Mechanical Engineering, having authored 37 papers that have together received 311 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Plant Molecular Biology Research (2 papers), Safety and Risk Management (2 papers), Photosynthetic Processes and Mechanisms (2 papers), Head and Neck Cancer Studies (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Cutaneous Melanoma Detection and Management (1 paper) and Mindfulness and Compassion Interventions (1 paper). The work is most often cited by research in Pharmacology (53 citations), Pharmacology (87 citations), Endocrinology, Diabetes and Metabolism (39 citations), Plant Science (83 citations) and Molecular Biology (144 citations). Dan Dan Li has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Ying Xu, Le Zhang, Xin‐Qi Gao, Changzhen Liu, Xian Sheng Zhang, Xin‐Ying Zhao, Ting Zhao, Shi H, Lian Lu and Dong Mei Zhang. Their work appears in journals such as IEEE Transactions on Components Packaging and Manufacturing Technology, International Journal of Medical Sciences, Frontiers in Immunology, Journal of Equine Veterinary Science and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.